The pharmacological implications in blood-brain barrier permeability assays. Drug delivery to the brain is a challenging evaluation to consider during novel compounds discovery stages to study central nervous pharmacokinetics in…
Organización Con más de 10 años de experiencia y 200 clientes en más de 20 países de todo el mundo, ReadyCell es el productor líder de kits celulares "ready-to-use" con…
ReadyCell collaborates in the BioPrintIA project as a specialized partner in the biotechnology sector. BioPrintIA is a subsidised R&D project that develops a next-generation medical device based on artificial intelligence,…
Readycell es una empresa biotecnológica de Barcelona que desarrolla, implementa y comercializa kits de base celular. Nos encontramos actualmente en una fase de expansión y consolidación y queremos incorporar en…
ReadyCell actively interacts with the Drug Discovery community, introducing cell-based in vitro systems and easing novel compounds’ preclinical development.